Tetrahydronaphthyridine derivatives
US7557121B2 · kind B2 · utility
2Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2005 |
| Grant date | Jul 7, 2009 |
| Priority date | — |
| Expiry date | Sep 26, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to tetrahydronaphthyridine derivatives of the general formula (I):or of the general formula (I′)in which A and R1 are as defined within, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, including the treatment diseases mediated by H3 ligands, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.